KeyCorp Has Lowered Expectations for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price objective lowered by investment analysts at KeyCorp from $35.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. KeyCorp’s price target would suggest a potential upside of 109.21% from the company’s previous close.

Several other equities analysts have also issued reports on the stock. Bank of America lowered shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and cut their price objective for the company from $27.00 to $25.00 in a report on Wednesday, September 10th. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. Guggenheim cut their target price on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. Finally, Raymond James Financial set a $22.00 target price on shares of Acadia Healthcare in a report on Friday, November 7th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $32.36.

Acadia Healthcare Price Performance

ACHC opened at $14.34 on Tuesday. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of 9.50, a PEG ratio of 4.56 and a beta of 0.97. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare has a 12-month low of $14.30 and a 12-month high of $47.08. The business’s fifty day simple moving average is $22.28 and its 200-day simple moving average is $22.45.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities research analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP raised its position in shares of Acadia Healthcare by 11.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock valued at $233,327,000 after purchasing an additional 993,205 shares during the last quarter. Vanguard Group Inc. increased its stake in Acadia Healthcare by 7.8% during the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after purchasing an additional 681,278 shares in the last quarter. Abrams Bison Investments LLC raised its holdings in shares of Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock worth $108,449,000 after buying an additional 800,000 shares during the last quarter. UBS Group AG lifted its stake in shares of Acadia Healthcare by 8.8% during the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after buying an additional 350,484 shares during the period. Finally, State Street Corp grew its holdings in shares of Acadia Healthcare by 3.2% during the second quarter. State Street Corp now owns 3,095,775 shares of the company’s stock valued at $70,243,000 after buying an additional 95,670 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.